Delivery Order SPE2DB20D3111-SPE2DB25FA9CS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product. This firm fixed-price delivery order, valued at $1,223.59, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of XDEMVY 0.25% drop in 10ml quantities, with a ceiling value of $1,223.59 and a firm fixed price structure. This non-set-aside competitive award is categorized as a delivery order with an ultimate completion date of September 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This firm fixed-price delivery order, valued at $1,223.59, represents a non-competitive award and is scheduled for completion by October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,670.77 to AmerisourceBergen Drug Corp on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is for XDEMVY 0.25% DROP 10ML pharmaceutical product and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The award involved no set-aside designation and was competitively awarded to the vendor. This...
- The Defense Logistics Agency awarded a $4,894.32 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of XDEMVY 0.25% Drop in 10ml quantities. This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of XDEMVY 0.25% drop in 10 ml quantities, with a ceiling value of $1,223.59. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and carries an ultimate completion date of May 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, serving as the place of performance. As a child contract vehicle,...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for pharmaceutical supplies valued at $1,223.59. The contract covers XDEMVY 0.25% DROP 10ML, a specialized pharmaceutical product, with an ultimate completion date of August 27, 2025. The award was made through a competitive process with no set-aside designation and utilizes firm fixed pricing. This delivery order will be fulfilled at AmerisourceBergen's corporate office location...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9CSDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical supplies, specifically XDEMVY 0.25% Drop in 10ml units. This firm fixed-price delivery order, valued at $3,670.77, represents a non-set-aside competitive award with a completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. As a child contract under this strategic vehicle, the current delivery order exemplifies AmerisourceBergen's role as a critical vendor supporting the Defense Health Agency and other federal healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/27/25 |